Carr Douglas 4
4 · Century Therapeutics, Inc. · Filed Jun 9, 2026
Research Summary
AI-generated summary of this filing
Century Therapeutics SVP Douglas Carr Sells 249 Shares
What Happened Douglas Carr, Senior Vice President of Finance & Operations at Century Therapeutics (IPSC), reported the sale of 249 shares on 2026-06-08. The shares were sold at $2.11 each for a total proceeds of $526. This was a sale to cover tax withholding tied to restricted stock unit (RSU) vesting, not an active discretionary investment decision.
Key Details
- Transaction date and price: 2026-06-08, 249 shares at $2.11 per share (total $526).
- Transaction type/code: Sale (reported as S); sale described as done to cover tax withholding.
- Footnote: The sale was automatic to satisfy tax withholding obligations related to RSU vesting (footnote F1).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Filing timeliness: Report filed 2026-06-09 for a 2026-06-08 transaction — appears timely (within Form 4 reporting rules).
Context This was an automatic, mandatory sale to cover taxes upon RSU vesting — a common, routine insider transaction that typically does not signal a change in the insider’s view of the company. The dollar amount is small ($526), so the trade is unlikely to be material to investor sentiment on its own.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-06-08$2.11/sh−249$526→ 506,748 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.